Lithium-induced nephrogenic diabetes insipidus: New clinical and experimental findings

Journal of Nephrology

Volumn 23, Issue SUPPL.16, 2010, Pages

  Trepiccione, Francesco ^a   Christensen, Birgitte Mønster ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

Collecting duct; Lithium; Nephrogenic diabetes insipidus

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; LITHIUM;

ANIMAL; CHEMICALLY INDUCED DISORDER; HUMAN; KIDNEY; KIDNEY COLLECTING TUBULE; METABOLISM; NEPHROGENIC DIABETES INSIPIDUS; PHYSIOLOGY; REVIEW;

ANIMALS; DIABETES INSIPIDUS, NEPHROGENIC; GLYCOGEN SYNTHASE KINASE 3; HUMANS; KIDNEY; KIDNEY TUBULES, COLLECTING; LITHIUM;

EID: 79952287009     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Lister-Williams RH. Relapse prevention in bipolar disorder: a critical review of current guidelines. J Psychopharmacol. 2006;20:12-16.
2. Fornai F, Longone P, Cafaro L, et al. Lithium delays progression of amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A. 2008;105:2052-2057.
3. Martinez A, Perez DI. GSK-3 inhibitors: a ray of hope for the treatment of Alzheimer's disease? J Alzheimers Dis. 2008;15:181-191.
4. Wallin L, Alling C, Aurell M. Impairment of renal function in patients on long-term lithium treatment. Clin Nephrol. 1982;18:23-28.
5. Presne C, Fakhouri F, Noel LH, et al. Lithium-induced nephropathy: rate of progression and prognostic factors. Kidney Int. 2003;64:585-592.
6. Batlle D, Gaviria M, Grupp M, Arruda JA, Wynn J, Kurtzman NA. Distal nephron function in patients receiving chronic lithium therapy. Kidney Int. 1982;21:477-485.
7. Ryves WJ, Harwood AJ. Lithium inhibits glycogen synthase kinase-3 by competition for magnesium. Biochem Biophys Res Commun. 2001;280:720-725.
8. Holstein-Rathlou NH. Lithium transport across biological membranes. Kidney Int Suppl. 1990;28:S4-S9.
9. Kinne R, Koenig B, Hannafin J, Kinne-Saffran E, Scott DM, Zierold K. The use of membrane vesicles to study the NaCl/KCl cotransporter involved in active transepithelial chloride transport. Pflugers Arch. 1985;405(Suppl 1):S101-S105.
10. Fleishman DG, Solyus AA, Gurevich ZP, Bagrov Y. Lithium in the human body. Hum Physiol. 1985;11:430-435.
11. Corman B, Roinel N, de Rouffignac C. Dependence of water movement on sodium transport in kidney proximal tubule: a microperfusion study substituting lithium for sodium. J Membr Biol. 1981;62:105-111.
12. Thomsen K. Lithium clearance: a new method for determining proximal and distal tubular reabsorption of sodium and water. Nephron. 1984;37:217-223.
13. Atherton JC, Doyle A, Gee A, et al. Lithium clearance: modification by the loop of Henle in man. J Physiol. 1991;437:377-391.
14. Unwin RJ, Walter SJ, Shirley DG. Lithium reabsorption in perfused loops of Henle: effects of perfusion rate and bumetanide. Am J Physiol. 1994;266:F806-F812.
15. Boer WH, Joles JA, Koomans HA, Dorhout Mees EJ. Decreased lithium clearance due to distal tubular lithium reabsorption in sodium-depleted dogs. Ren Physiol. 1987;10:65-68.
16. Kirchner KA. Lithium as a marker for proximal tubular delivery during low salt intake and diuretic infusion. Am J Physiol. 1987;253:F188-F196.
17. Boer WH, Koomans HA, Dorhout Mees EJ. Acute effects of thiazides, with and without carbonic anhydrase inhibiting activity, on lithium and free water clearance in man. Clin Sci (Lond). 1989;76:539-545.
18. Pedersen RS, Bentzen H, Bech JN, Pedersen EB. Effect of an acute oral lithium intake on urinary Aquaporin-2 in healthy humans with and without simultaneous stimulation with hypertonic saline infusion. Scand J Clin Lab Invest. 2003;63:181-194.
19. Walker RJ, Weggery S, Bedford JJ, McDonald FJ, Ellis G, Leader JP. Lithium-induced reduction in urinary concentrating ability and urinary aquaporin 2 (AQP2) excretion in healthy volunteers. Kidney Int. 2005;67:291-294.
20. Padfield PL, Park SJ, Morton JJ, Braidwood AE. Plasma levels of antidiuretic hormone in patients receiving prolonged lithium therapy. Br J Psychiatry. 1977;130:144-147.
21. Forrest JN Jr, Cohen AD, Torretti J, Himmelhoch JM, Epstein FH. On the mechanism of lithium-induced diabetes insipidus in man and the rat. J Clin Invest. 1974;53:1115-1123.
22. Ljubicic D, Letica-Crepulja M, Vitezic D, Bistrovic IL, Ljubicic R. Lithium treatments: single and multiple daily dosing. Can J Psychiatry. 2008;53:323-331.
23. Boton R, Gaviria M, Batlle DC. Prevalence, pathogenesis, and treatment of renal dysfunction associated with chronic lithium therapy. Am J Kidney Dis. 1987;10:329-345.
24. Bucht G, Wahlin A. Renal concentrating capacity in longterm lithium treatment and after withdrawal of lithium. Acta Med Scand. 1980;207:309-314.
25. Bendz H, Sjodin I, Aurell M. Renal function on and off lithium in patients treated with lithium for 15 years or more: a controlled, prospective lithium-withdrawal study. Nephrol Dial Transplant. 1996;11:457-460.
26. Walker RG, Escott M, Birchall I, Dowling JP, Kincaid-Smith P. Chronic progressive renal lesions induced by lithium. Kidney Int. 1986;29:875-881.
27. Hansen HE, Hestbech J, Sorensen JL, Norgaard K, Heilskov J, Amdisen A. Chronic interstitial nephropathy in patients on long-term lithium treatment. Q J Med. 1979;48:577-591.
28. Farres MT, Ronco P, Saadoun D, et al. Chronic lithium nephropathy: MR imaging for diagnosis. Radiology. 2003;229:570-574.
29. Batlle DC, von Riotte AB, Gaviria M, Grupp M. Amelioration of polyuria by amiloride in patients receiving long-term lithium therapy. N Engl J Med. 1985;312:408-414.
30. Bedford JJ, Weggery S, Ellis G, et al. Lithium-induced nephrogenic diabetes insipidus: renal effects of amiloride. Clin J Am Soc Nephrol. 2008;3:1324-1331.
31. Allen HM, Jackson RL, Winchester MD, Deck LV, Allon M. Indomethacin in the treatment of lithium-induced nephrogenic diabetes insipidus. Arch Intern Med. 1989;149:1123-1126.
32. Kwon TH, Laursen UH, Marples D, et al. Altered expression of renal AQPs and Na(+) transporters in rats with lithium-induced NDI. Am J Physiol Renal Physiol. 2000;279:F552-F564.
33. Christensen BM, Loffing J, Hummler E, Rossier BC. Collecting duct-specific gene inactivation of alpha ENaC protects mice against lithium-induced nephrogenic diabetes insipidus [abstract]. J Am Soc Nephrol. 2006;17:295A.
34. Kortenoeven ML, Li Y, Shaw S, et al. Amiloride blocks lithium entry through the sodium channel thereby attenuating the resultant nephrogenic diabetes insipidus. Kidney Int. 2009;76:44-53.
35. Zerbini G, Maestroni A, Mangili R, Pozza G. Amilorideinsensitive Na+-H+ exchange: a candidate mediator of erythrocyte Na+-Li+ countertransport. J Am Soc Nephrol. 1998;9:2203-2211.
36. Jackson BA, Edwards RM, Dousa TP. Lithium-induced polyuria: effect of lithium on adenylate cyclase and adenosine 3',5'-monophosphate phosphodiesterase in medullary ascending limb of Henle's loop and in medullary collecting tubules. Endocrinology. 1980;107:1693-1698.
37. Li Y, Shaw S, Kamsteeg EJ, Vandewalle A, Deen PM. Development of lithium-induced nephrogenic diabetes insipidus is dissociated from adenylyl cyclase activity. J Am Soc Nephrol. 2006;17:1063-1072.
38. Kuure S, Popsueva A, Jakobson M, Sainio K, Sariola H. Glycogen synthase kinase-3 inactivation and stabilization of betacatenin induce nephron differentiation in isolated mouse and rat kidney mesenchymes. J Am Soc Nephrol. 2007;18:1130-1139.
39. Nielsen J, Hoffert JD, Knepper MA, Agre P, Nielsen S, Fenton RA. Proteomic analysis of lithium-induced nephrogenic diabetes insipidus: mechanisms for aquaporin 2 down-regulation and cellular proliferation. Proc Natl Acad Sci U S A. 2008;105:3634-3639.
40. Christensen BM, Kim YH, Kwon TH, Nielsen S. Lithium treatment induces a marked proliferation of primarily principal cells in rat kidney inner medullary collecting duct. Am J Physiol Renal Physiol. 2006;291:F39-F48.
41. Bansal AD, Hoffert JD, Pisitkun T, et al. Phosphoproteomic profiling reveals vasopressin-regulated phosphorylation sites in collecting duct. J Am Soc Nephrol. 2010;21:303-315.
42. Rao R, Zhang MZ, Zhao M, et al. Lithium treatment inhibits renal GSK-3 activity and promotes cyclooxygenase 2-dependent polyuria. Am J Physiol Renal Physiol. 2005;288:F642-F649.
43. Zhang Y, Kohan DE, Nelson RD, Carlson NG, Kishore BK. Potential involvement of P2Y2 receptor in diuresis of postobstructive uropathy in rats. Am J Physiol Renal Physiol. 2010;298:F634-F642.
44. Christensen BM, Marples D, Kim YH, Wang W, Frokiaer J, Nielsen S. Changes in cellular composition of kidney collecting duct cells in rats with lithium-induced NDI. Am J Physiol Cell Physiol. 2004;286:C952-C964.
45. Ou Y, Ruan Y, Cheng M, Moser JJ, Rattner JB, van der Hoorn FA. Adenylate cyclase regulates elongation of mammalian primary cilia. Exp Cell Res. 2009;315:2802-2817.